AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • May 4th, 2017 • Juniper Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (as the same may be amended, restated, supplemented or otherwise modified from time to time hereafter, the “Agreement”) is effective as of April 12, 2017 (the “Effective Date”), and is entered into by and between Juniper Pharmaceuticals, Inc., a Delaware corporation having its corporate offices at 33 Arch St, Suite 3110, Boston, MA 02110 (the “Company”), and Alicia Secor (“Executive”). This Agreement supersedes, amends and restates in all respects the Employment Agreement dated August 1, 2016 between Executive and the Company, and all other employment agreements between Executive and the Company (collectively, the “Superseded Employment Agreements”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • May 4th, 2017 • Juniper Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (as the same may be amended, restated, supplemented or otherwise modified from time to time hereafter, this “Agreement”) is effective as of April 12, 2017 (the “Effective Date”), and is entered into by and between Juniper Pharmaceuticals, Inc., a Delaware corporation having its corporate offices at 33 Arch St, Suite 3110, Boston, MA, 02110 (the “Company”), and Bridget A. Martell, MD MA (“Executive”).
THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT is made this 27th day of April, 2017 (the “Effective Date”). BETWEEN: IT IS AGREED as followsEmployment Agreement • May 4th, 2017 • Juniper Pharmaceuticals Inc • Pharmaceutical preparations
JUNIPER PHARMACEUTICALS, INC. AMENDED AND RESTATED 2015 LONG-TERM INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD AGREEMENTRestricted Stock Unit Award Agreement • May 4th, 2017 • Juniper Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This Award Agreement sets forth the terms and conditions of Stock Units granted pursuant to the provisions of the Amended and Restated 2015 Long-Term Incentive Plan (the “Plan”) of Juniper Pharmaceuticals, Inc. (the “Company”) to the Participant whose name appears below, for the number of Stock Units set forth below (the “Award”), pursuant to the provisions of the Plan and on the following express terms and conditions. Capitalized terms not otherwise defined herein shall have the same meanings as set forth in the Plan.
Addendum to Transition and Consulting AgreementConsulting Agreement • May 4th, 2017 • Juniper Pharmaceuticals Inc • Pharmaceutical preparations
WHEREAS, Juniper Pharmaceuticals, Inc. (the “Company”) and Frank C. Condella, Jr. (the “Executive”), are parties to that certain Transition and Consulting Agreement, dated as of July 19, 2016 (the “Consulting Agreement”); and
PERFORMANCE STOCK UNIT AWARD AGREEMENT JUNIPER PHARMACEUTICALS, INC. AMENDED AND RESTATED 2015 LONG-TERM INCENTIVE PLANPerformance Stock Unit Award Agreement • May 4th, 2017 • Juniper Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS AGREEMENT (the “Agreement”) is made effective as of the __ day of _________, 20[__] (hereinafter called the “Date of Grant”), between Juniper Pharmaceuticals, Inc., a Delaware corporation (hereinafter called the “Company”), and ______________ (hereinafter called the “Participant”):
